HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 28-30 | Hybrid Event

September 28-30, 2026 | London, UK

Vaccine Biotechnology

Vaccine Biotechnology

Vaccine biotechnology represents a groundbreaking and transformative field within the realm of life sciences. It involves the application of advanced biological and molecular techniques to the development, production, and enhancement of vaccines. Biotechnological methods, such as genetic engineering, recombinant DNA technology, and innovative cell culture processes, play a pivotal role in designing and manufacturing vaccines. These cutting-edge approaches enable scientists to create vaccines with increased efficacy, improved safety profiles, and a broader spectrum of protection against infectious diseases. The synergy between biotechnology and vaccine development has paved the way for revolutionary breakthroughs, allowing for the rapid response to emerging pathogens and the customization of vaccines for various populations. The ongoing advancements in vaccine biotechnology hold immense promise for addressing global health challenges and fostering a new era of preventive medicine.

Committee Members
Speaker at Biotechnology and Bioengineering 2026 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
Speaker at Biotechnology and Bioengineering 2026 - Limongi Tania

Limongi Tania

University of Turin, Italy
Speaker at Biotechnology and Bioengineering 2026 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico

Submit your abstract Today

Watsapp